Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.
Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check6 days agoChange DetectedThe NIH transition announcement banner is no longer displayed above the ClinicalTrials.gov page, which continues to show a 403 error.SummaryDifference1%
- Check13 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%
- Check20 days agoChange DetectedA sitewide NIH notice announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%
- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision was updated from v3.7.1 to v3.7.2, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%
- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%
- Check56 days agoChange DetectedThe study record page now displays a 403 Forbidden error screen, replacing the detailed trial information with an access-denied message. The header remains visible, but the core content about the trial is not loaded or accessible.SummaryDifference18%
Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.